Mergers & Acquisitions - Mergers & Acquisitions, Generics, USA

Filter

Impax Labs goes on a $700 million buying spree

Impax Labs goes on a $700 million buying spree

09-10-2014

US generic drugmaker Impax Laboratories saw its shares leap 11.2% to $26.52 in pre-market trading today,…

Amedra PharmaceuticalsCorePharmaGenericsImpax LaboratoriesLineage TherapeuticsMergers & AcquisitionsTaiwanUSA

FTC approves final order on Akorn divestment in bid for VersaPharm

FTC approves final order on Akorn divestment in bid for VersaPharm

21-09-2014

Following a public comment period, the US Federal Trade Commission has approved a final order settling…

AkornAntibiotics and Infectious diseasesGenericsLegalMergers & AcquisitionsRifampinUSAVersaPharm

Mylan to acquire US rights to Arixtra Injection from Aspen

Mylan to acquire US rights to Arixtra Injection from Aspen

10-09-2014

US generic drugs major Mylan has entered into an agreement to acquire the US commercialization, marketing…

ArixtraAspen PharmacareCardio-vascularGenericsGlaxoSmithKlineMergers & AcquisitionsMylanUSA

FTC puts conditions on Akorn’s proposed acquisition of VersaPharm

FTC puts conditions on Akorn’s proposed acquisition of VersaPharm

05-08-2014

The US Federal Trade Commission revealed yesterday that US generics drugmaker Akorn has agreed to sell…

AkornAntibiotics and Infectious diseasesClinical researchGeneric injectable tuberculosisGenericsMergers & AcquisitionsRegulationRifampinUSAVersaPharm

ANI Pharma acquires Vancocin assets from Shire

ANI Pharma acquires Vancocin assets from Shire

02-08-2014

US generic drugmaker ANI Pharmaceuticals says it has acquired the US rights for the antibiotic Vancocin…

ANI PharmaceuticalsAntibiotics and Infectious diseasesEli Lilly and CompanyGenericsGlycopeptide antibioticsIrelandMergers & AcquisitionsNew DrugShireUSAVancocinVancomycin HCl

Hikma to take over Boehringer’s Ben Venue manufacturing site

24-07-2014

Jordan-based drugmaker Hikma Pharmaceuticals says it has agreed with Ben Venue Laboratories, part of…

Ben Venue LabsBoehringer IngelheimGenericsHikma PharmaceuticalsMergers & AcquisitionsProductionUSA

FTC approves final order on Akorn’s acquisition of Hi-Tech

FTC approves final order on Akorn’s acquisition of Hi-Tech

22-06-2014

Following a public comment period, the US Federal Trade Commission on Friday approved a final order settling…

AkornGenericsHi-Tech PharmacalMergers & AcquisitionsUSAValeant Pharmaceuticals International

Hikma to buy Boehringer’s Bedford Labs unit for $300 million

Hikma to buy Boehringer’s Bedford Labs unit for $300 million

28-05-2014

Jordon-based drugmaker Hikma Pharmaceuticals has signed an asset purchase agreement with Ben Venue Laboratories,…

Bedford LaboratoriesBoehringer IngelheimGenericsHikma PharmaceuticalsMergers & AcquisitionsUSA

Sun Pharma vows “appropriate action” as Ranbaxy merger halted

05-05-2014

In the wake of a suspension of its proposed $4 billion acquisition of domestic rival Ranbaxy Laboratories…

GenericsIndiaMergers & AcquisitionsProductionRanbaxy LaboratoriesSun Pharmaceutical IndustriesUSA

FTC imposes conditions on Akorn’s proposed buy of Hi-Tech Pharmacal

15-04-2014

In order to consummate the proposed $640 million acquisition of Hi-Tech Pharmacal by fellow USA-based…

ActavisAkornGenericsHi-Tech PharmacalMergers & AcquisitionsNorth AmericaUSA

US regulator calls for divestment for Endo Health’s acquisition of Boca Pharmacal to proceed

US regulator calls for divestment for Endo Health’s acquisition of Boca Pharmacal to proceed

02-02-2014

US specialty health care firm Endo Health Solutions and its takeover target generic drugmaker Boca Pharmacal…

Boca PharmacalEndo Health SolutionsGenericsMergers & AcquisitionsNorth AmericaRegulationUSA

Back to top